Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00784485 · ClinicalTrials.gov registry record · Phase 4
Non-invasive Measures of Effects of Xolair in Asthma
A Phase 4 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT00784485 is a Phase 4 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 13 participants.
The verdict
NCT00784485, a Phase 4 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the effectiveness of Xolair® (omalizumab) in people with asthma taking Advair Diskus®. The study will look at the effects of Xolair® on lung function using high resolution computed tomography (HRCT) scans after asthma symptoms are induced with a special substance called methacholine. This study is only taking place at UCLA, where about 13 subjects will be enrolled. Participation requires 10-14 visits over about 26 weeks. Subjects will receive an albuterol inhaler to use as needed for immediate relief of symptoms and fluticasone 250 mcg/salmeterol 50 mcg or fluticasone 500 mcg/salmeterol 50 mcg (Advair Diskus® 250/50 or 500/50) to be taken twice daily. At certain visits, they will be given Xolair® injections followed by various assessments, including CT scans and lung function tests.
Interventions
- DRUG Xolair injections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00784485
The ClinicalTrials.gov registry entry for NCT00784485 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Xolair injections is the first listed.
NCT00784485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00784485 about?
NCT00784485 is a clinical study titled "Non-invasive Measures of Effects of Xolair in Asthma". The purpose of this study is to look at the effectiveness of Xolair® (omalizumab) in people with asthma taking Advair Diskus®. The study will look at the effects of Xolair® on lung function using high resolution computed tomography (HRCT) scans after asthma symptoms are induced with a special substa...
What is the current status of trial NCT00784485?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2009-02. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00784485?
The interventions under investigation include: Xolair injections (DRUG).
Who is sponsoring clinical trial NCT00784485?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.